Technology
Self-assembly as the delivery mechanism
A short peptide is cheap to make and easy to change. The problem is that an unfunctionalised peptide is short-lived and weakly binding. Saphtx’s answer is to give each peptide two domains: one that binds the target, and one that drives it to assemble with its neighbours into a fibril.
The fibril is the active object: it presents many binding sites at once, and its composition — which peptides, in what ratio — sets what it presents.
Properties
Six things that follow from the design
Two domains per peptide
One domain is designed to bind a specific viral protein; the other self-assembles into fibrils. The mix sets the epitope displayed on the surface.
Tunable composition
Fibril binding characteristics are determined by the types of peptides and their molar fractions, so the architecture can be re-pointed at a new target.
Multivalent by design
A fibril presents many binding sites at once, which is how it maintains strong binding to viral protein complexes.
Resilient to mutation
The paper reports that the assembled fibrils retain high resilience to viral mutations.
Small and stable
Self-assembled peptides are about twenty times smaller than antibodies and more stable than unfunctionalised peptides.
Cheap and scalable
The Nature Communications paper describes the platform as efficacious, inexpensive and stable, with excellent tolerability.
Evidence
What has been shown, and how
The antiviral work is published: hetero-peptides self-assembling into β-sheets, tested experimentally and computationally with short peptides that bind the Spike protein of SARS-CoV-2. The paper reports that the fibrils keep enhanced binding to viral protein complexes and remain resilient to viral mutations.
The ocular programme was presented as an abstract at the Biomaterials Society in 2019, and is described on this site as a proposed solution rather than a completed trial.
Work with us
Protein-based therapeutics, translated
Saphtx works with academic inventors to translate engineered proteins toward the clinic. If you would like to work with the company, its inbox is public.